BYMIX Performance — BNY Mellon Corporate Bond Fund, Investor Shares
Data updated: 2026-01-26
BYMIX returned +6.39% over one year to Nov 2025. Annualised returns are +6.98% over 3 years and +1.72% over 5 years. Against its Intermediate Corporate Bond category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $122, against $120 for the category, and to $106 over one year, against $106. Volatility over the past three years was 4.71% a year. In the 12 months to Nov 2025 the fund lost a net $20.6M, and assets reached $403.64M.
BYMIX Growth of $100
What $100 invested in BNY Mellon Corporate Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Corporate Bond category average over the same months.
| Period | BYMIX | Category average |
|---|---|---|
| 1 year (Dec 2024 – Nov 2025) | $106 | $106 |
| 3 years (Dec 2022 – Nov 2025) | $122 | $120 |
| 5 years (Dec 2020 – Nov 2025) | $109 | $106 |
| Since data start (Sep 2019 – Nov 2025) | $118 | $115 |
BYMIX Trailing Returns
Total returns to Nov 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +6.39% |
| 3 years (annualised) | +6.98% |
| 5 years (annualised) | +1.72% |
BYMIX Annual Returns
Calendar-year total returns of BNY Mellon Corporate Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Nov) | +7.54% |
| 2024 | +4.64% |
| 2023 | +8.86% |
| 2022 | −11.78% |
| 2021 | −0.13% |
| 2020 | +7.93% |
| 2019 (Sep–Dec) | +1.02% |
BYMIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.6% | +1.7% | −0.1% | 0.0% | +0.4% | +1.5% | +0.2% | +1.1% | +1.0% | +0.3% | +0.6% | — |
| 2024 | +0.6% | −0.8% | +1.1% | −1.5% | +1.7% | +0.6% | +2.0% | +1.1% | +1.4% | −1.5% | +1.0% | −1.1% |
| 2023 | +3.6% | −1.9% | +1.0% | +0.9% | −0.8% | +0.2% | +1.0% | 0.0% | −1.3% | −1.1% | +4.0% | +3.2% |
| 2022 | −2.0% | −1.5% | −2.6% | −3.3% | +0.4% | −2.5% | +2.5% | −2.0% | −3.8% | −0.5% | +3.4% | −0.1% |
| 2021 | −0.1% | −0.8% | −0.9% | +1.0% | +0.5% | +0.8% | +0.9% | −0.2% | −0.5% | −0.5% | −0.3% | +0.1% |
| 2020 | +1.9% | +0.8% | −8.4% | +4.2% | +1.9% | +2.5% | +2.1% | +0.2% | 0.0% | 0.0% | +2.1% | +0.9% |
| 2019 | — | — | — | — | — | — | — | — | −0.2% | +0.7% | 0.0% | +0.5% |
BYMIX Risk
Risk measures from monthly returns over Dec 2022 – Nov 2025.
- 3-year volatility (annualised): 4.71%
- 3-year Sharpe ratio: 0.53 (vs 4.5% risk-free rate)
- Best month: +3.95% (Nov 2023)
- Worst month: −1.92% (Feb 2023)
BYMIX Fund Flows
Monthly money in and out of BNY Mellon Corporate Bond Fund, from SEC Form N-PORT.
- 12-month net flow: −$20.6M
- 12-month gross sales (incl. reinvestments): $99.0M
- Sales ÷ redemptions: 0.83×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2025 | $4.9M | $5.4M | −$486K |
| Oct 2025 | $8.5M | $16.6M | −$8.0M |
| Sep 2025 | $7.1M | $14.6M | −$7.4M |
| Aug 2025 | $8.6M | $7.7M | $973K |
| Jul 2025 | $13.0M | $5.1M | $7.9M |
| Jun 2025 | $15.3M | $6.7M | $8.6M |
| May 2025 | $5.5M | $8.1M | −$2.7M |
| Apr 2025 | $11.0M | $12.6M | −$1.6M |
| Mar 2025 | $4.1M | $9.2M | −$5.1M |
| Feb 2025 | $6.6M | $10.8M | −$4.2M |
| Jan 2025 | $8.4M | $7.7M | $695K |
| Dec 2024 | $6.0M | $15.3M | −$9.3M |
BYMIX Assets Under Management
Net assets of BNY Mellon Corporate Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-11-30 | $403.64M |
| 2025-08-31 | $415.80M |
| 2025-05-31 | $390.70M |
| 2025-02-28 | $402.68M |
| 2024-11-30 | $415.51M |
| 2024-08-31 | $417.26M |
| 2024-05-31 | $420.43M |
| 2024-02-29 | $422.47M |
| 2023-11-30 | $409.83M |
| 2023-08-31 | $421.45M |
| 2023-05-31 | $425.93M |
| 2023-02-28 | $448.93M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.